Literature DB >> 10722623

gammadelta T cells are a component of early immunity against preerythrocytic malaria parasites.

K C McKenna1, M Tsuji, M Sarzotti, J B Sacci, A A Witney, A F Azad.   

Abstract

We tested the hypothesis that gammadelta T cells are a component of an early immune response directed against preerythrocytic malaria parasites that are required for the induction of an effector alphabeta T-cell immune response generated by irradiated-sporozoite (irr-spz) immunization. gammadelta T-cell-deficient (TCRdelta(-/-)) mice on a C57BL/6 background were challenged with Plasmodium yoelii (17XNL strain) sporozoites, and then liver parasite burden was measured at 42 h postchallenge. Liver parasite burden was measured by quantification of parasite-specific 18S rRNA in total liver RNA by quantitative-competitive reverse transcription-PCR and by an automated 5' exonuclease PCR. Sporozoite-challenged TCRdelta(-/-) mice showed a significant (P < 0.01) increase in liver parasite burden compared to similarly challenged immunocompetent mice. In support of this result, TCRdelta(-/-) mice were also found to be more susceptible than immunocompetent mice to a sporozoite challenge when blood-stage parasitemia was used as a readout. A greater percentage of TCRdelta(-/-) mice than of immunocompetent mice progressed to a blood-stage infection when challenged with five or fewer sporozoites (odds ratio = 2.35, P = 0.06). TCRdelta(-/-) mice receiving a single irr-spz immunization showed percent inhibition of liver parasites comparable to that of immunized immunocompetent mice following a sporozoite challenge. These data support the hypothesis that gammadelta T cells are a component of early immunity directed against malaria preerythrocytic parasites and suggest that gammadelta T cells are not required for the induction of an effector alphabeta T-cell immune response generated by irr-spz immunization.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10722623      PMCID: PMC97407          DOI: 10.1128/IAI.68.4.2224-2230.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  35 in total

1.  Specificity of protection of man immunized against sporozoite-induced falciparum malaria.

Authors:  D F Clyde; V C McCarthy; R M Miller; R B Hornick
Journal:  Am J Med Sci       Date:  1973-12       Impact factor: 2.378

2.  Inhibition of Plasmodium falciparum in vitro by human gamma delta T cells.

Authors:  M M Elloso; H C van der Heyde; J A vande Waa; D D Manning; W P Weidanz
Journal:  J Immunol       Date:  1994-08-01       Impact factor: 5.422

3.  A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group.

Authors:  J A Stoute; M Slaoui; D G Heppner; P Momin; K E Kester; P Desmons; B T Wellde; N Garçon; U Krzych; M Marchand
Journal:  N Engl J Med       Date:  1997-01-09       Impact factor: 91.245

4.  Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine.

Authors:  R Wang; D L Doolan; T P Le; R C Hedstrom; K M Coonan; Y Charoenvit; T R Jones; P Hobart; M Margalith; J Ng; W R Weiss; M Sedegah; C de Taisne; J A Norman; S L Hoffman
Journal:  Science       Date:  1998-10-16       Impact factor: 47.728

5.  Kupffer cell elimination enhances development of liver schizonts of Plasmodium berghei in rats.

Authors:  S G Vreden; R W Sauerwein; J P Verhave; N Van Rooijen; J H Meuwissen; M F Van Den Broek
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

6.  Differential production of interferon-gamma and interleukin-4 in response to Th1- and Th2-stimulating pathogens by gamma delta T cells in vivo.

Authors:  D A Ferrick; M D Schrenzel; T Mulvania; B Hsieh; W G Ferlin; H Lepper
Journal:  Nature       Date:  1995-01-19       Impact factor: 49.962

7.  Development of antimalaria immunity in mice lacking IFN-gamma receptor.

Authors:  M Tsuji; Y Miyahira; R S Nussenzweig; M Aguet; M Reichel; F Zavala
Journal:  J Immunol       Date:  1995-05-15       Impact factor: 5.422

8.  The role of gamma delta T cells in priming macrophages to produce tumor necrosis factor-alpha.

Authors:  H Nishimura; M Emoto; K Hiromatsu; S Yamamoto; K Matsuura; H Gomi; T Ikeda; S Itohara; Y Yoshikai
Journal:  Eur J Immunol       Date:  1995-05       Impact factor: 5.532

9.  CD4+ cytolytic T cell clone confers protection against murine malaria.

Authors:  M Tsuji; P Romero; R S Nussenzweig; F Zavala
Journal:  J Exp Med       Date:  1990-11-01       Impact factor: 14.307

10.  A protective role of gamma/delta T cells in primary infection with Listeria monocytogenes in mice.

Authors:  K Hiromatsu; Y Yoshikai; G Matsuzaki; S Ohga; K Muramori; K Matsumoto; J A Bluestone; K Nomoto
Journal:  J Exp Med       Date:  1992-01-01       Impact factor: 14.307

View more
  16 in total

Review 1.  γδ T cells in tissue physiology and surveillance.

Authors:  Julie C Ribot; Noëlla Lopes; Bruno Silva-Santos
Journal:  Nat Rev Immunol       Date:  2020-10-14       Impact factor: 53.106

2.  γδ-T cells promote IFN-γ-dependent Plasmodium pathogenesis upon liver-stage infection.

Authors:  Julie C Ribot; Rita Neres; Vanessa Zuzarte-Luís; Anita Q Gomes; Liliana Mancio-Silva; Sofia Mensurado; Daniel Pinto-Neves; Miguel M Santos; Tânia Carvalho; Jonathan J M Landry; Eva A Rolo; Ankita Malik; Daniel Varón Silva; Maria M Mota; Bruno Silva-Santos; Ana Pamplona
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-26       Impact factor: 11.205

3.  Response to Comment on "γδ T Cells Are Required for the Induction of Sterile Immunity during Irradiated Sporozoite Vaccinations".

Authors:  Irfan Zaidi; Patrick E Duffy
Journal:  J Immunol       Date:  2018-03-01       Impact factor: 5.422

4.  Cerebral malaria in mice: interleukin-2 treatment induces accumulation of gammadelta T cells in the brain and alters resistant mice to susceptible-like phenotype.

Authors:  A Haque; H Echchannaoui; R Seguin; J Schwartzman; L H Kasper; S Haque
Journal:  Am J Pathol       Date:  2001-01       Impact factor: 4.307

5.  Immunogenicity and protective efficacy of a Plasmodium yoelii Hsp60 DNA vaccine in BALB/c mice.

Authors:  G I Sanchez; M Sedegah; W O Rogers; T R Jones; J Sacci; A Witney; D J Carucci; N Kumar; S L Hoffman
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

Review 6.  Immunity to liver stage malaria: considerations for vaccine design.

Authors:  Andrew W Taylor-Robinson
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

7.  Generation and first characterization of TRDC-knockout pigs lacking γδ T cells.

Authors:  Bjoern Petersen; Robert Kammerer; Antje Frenzel; Petra Hassel; Tung Huy Dau; Roswitha Becker; Angele Breithaupt; Reiner Georg Ulrich; Andrea Lucas-Hahn; Gregor Meyers
Journal:  Sci Rep       Date:  2021-07-22       Impact factor: 4.379

8.  Highly sensitive quantitative real-time PCR for the detection of Plasmodium liver-stage parasite burden following low-dose sporozoite challenge.

Authors:  Sophie Schussek; Penny L Groves; Simon H Apte; Denise L Doolan
Journal:  PLoS One       Date:  2013-10-02       Impact factor: 3.240

Review 9.  Immune evasion strategies of pre-erythrocytic malaria parasites.

Authors:  Hong Zheng; Zhangping Tan; Wenyue Xu
Journal:  Mediators Inflamm       Date:  2014-05-07       Impact factor: 4.711

10.  A highly infectious Plasmodium yoelii parasite, bearing Plasmodium falciparum circumsporozoite protein.

Authors:  Min Zhang; Izumi Kaneko; Tiffany Tsao; Robert Mitchell; Elizabeth H Nardin; Shiroh Iwanaga; Masao Yuda; Moriya Tsuji
Journal:  Malar J       Date:  2016-04-12       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.